The novel autophagy inhibitor ROC-325 augments the antileukemic activity of azacitidine
Leukemia, Published online: 29 July 2019; doi:10.1038/s41375-019-0529-2The novel autophagy inhibitor ROC-325 augments the antileukemic activity of azacitidine
Source: Leukemia - Category: Hematology Authors: Steffan T. Nawrocki Yingchun Han Valeria Visconte Bartlomiej Przychodzen Claudia M. Espitia James Phillips Faiz Anwer Anjali Advani Hetty E. Carraway Kevin R. Kelly Mikkael A. Sekeres Jaroslaw P. Maciejewski Jennifer S. Carew Source Type: research
More News: Hematology | Leukemia